The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Alpha-1 antitrypsin deficiency (AATD) is an inherited condition characterized as a low or unpredictable level of alpha-1 protein, generated by liver. The disease most commonly affects lungs and liver and is often undiagnosed. Augmentation therapy is the most specific therapy for the treatment of AATD, and includes various preparations derived from pooled human plasma.
The global Alpha-1 Antitrypsin Deficiency Augmentation Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Alpha-1 Antitrypsin Deficiency Augmentation Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alpha-1 Antitrypsin Deficiency Augmentation Therapy.
Report Scope
The Alpha-1 Antitrypsin Deficiency Augmentation Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alpha-1 Antitrypsin Deficiency Augmentation Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alpha-1 Antitrypsin Deficiency Augmentation Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Grifols
- CSL
- Baxter
- Kamada
- Takeda
- Abeona
Segment by Type
- Glassia
- Aralast NP
- Prolastin C
- Others
Segment by Application
- Hospitals
- Specialty Clinics
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alpha-1 Antitrypsin Deficiency Augmentation Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Glassia
1.2.3 Aralast NP
1.2.4 Prolastin C
1.2.5 Others
1.3 Market by Application
1.3.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Perspective (2019-2030)
2.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Growth Trends by Region
2.2.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Historic Market Size by Region (2019-2024)
2.2.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Region (2025-2030)
2.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Dynamics
2.3.1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Industry Trends
2.3.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Drivers
2.3.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Challenges
2.3.4 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Revenue
3.1.1 Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Revenue (2019-2024)
3.1.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue
3.4 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Concentration Ratio
3.4.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in 2023
3.5 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Key Players Head office and Area Served
3.6 Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Solution and Service
3.7 Date of Enter into Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Breakdown Data by Type
4.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Historic Market Size by Type (2019-2024)
4.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Type (2025-2030)
5 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Breakdown Data by Application
5.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Historic Market Size by Application (2019-2024)
5.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2019-2030)
6.2 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2019-2024)
6.4 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2019-2030)
7.2 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2019-2024)
7.4 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2019-2030)
8.2 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2019-2030)
9.2 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2019-2024)
9.4 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2019-2030)
10.2 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Grifols
11.1.1 Grifols Company Detail
11.1.2 Grifols Business Overview
11.1.3 Grifols Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.1.4 Grifols Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2019-2024)
11.1.5 Grifols Recent Development
11.2 CSL
11.2.1 CSL Company Detail
11.2.2 CSL Business Overview
11.2.3 CSL Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.2.4 CSL Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2019-2024)
11.2.5 CSL Recent Development
11.3 Baxter
11.3.1 Baxter Company Detail
11.3.2 Baxter Business Overview
11.3.3 Baxter Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.3.4 Baxter Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2019-2024)
11.3.5 Baxter Recent Development
11.4 Kamada
11.4.1 Kamada Company Detail
11.4.2 Kamada Business Overview
11.4.3 Kamada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.4.4 Kamada Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2019-2024)
11.4.5 Kamada Recent Development
11.5 Takeda
11.5.1 Takeda Company Detail
11.5.2 Takeda Business Overview
11.5.3 Takeda Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.5.4 Takeda Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2019-2024)
11.5.5 Takeda Recent Development
11.6 Abeona
11.6.1 Abeona Company Detail
11.6.2 Abeona Business Overview
11.6.3 Abeona Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.6.4 Abeona Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2019-2024)
11.6.5 Abeona Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Glassia
Table 3. Key Players of Aralast NP
Table 4. Key Players of Prolastin C
Table 5. Key Players of Others
Table 6. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Region (2019-2024)
Table 10. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Region (2025-2030)
Table 12. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Trends
Table 13. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Drivers
Table 14. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Challenges
Table 15. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Restraints
Table 16. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Players (2019-2024)
Table 18. Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy as of 2023)
Table 19. Ranking of Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Solution and Service
Table 23. Date of Enter into Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Type (2019-2024)
Table 27. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Type (2025-2030)
Table 29. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Application (2019-2024)
Table 31. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Application (2025-2030)
Table 33. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 48. Grifols Company Detail
Table 49. Grifols Business Overview
Table 50. Grifols Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 51. Grifols Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2019-2024) & (US$ Million)
Table 52. Grifols Recent Development
Table 53. CSL Company Detail
Table 54. CSL Business Overview
Table 55. CSL Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 56. CSL Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2019-2024) & (US$ Million)
Table 57. CSL Recent Development
Table 58. Baxter Company Detail
Table 59. Baxter Business Overview
Table 60. Baxter Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 61. Baxter Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2019-2024) & (US$ Million)
Table 62. Baxter Recent Development
Table 63. Kamada Company Detail
Table 64. Kamada Business Overview
Table 65. Kamada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 66. Kamada Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2019-2024) & (US$ Million)
Table 67. Kamada Recent Development
Table 68. Takeda Company Detail
Table 69. Takeda Business Overview
Table 70. Takeda Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 71. Takeda Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2019-2024) & (US$ Million)
Table 72. Takeda Recent Development
Table 73. Abeona Company Detail
Table 74. Abeona Business Overview
Table 75. Abeona Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 76. Abeona Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2019-2024) & (US$ Million)
Table 77. Abeona Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type: 2023 VS 2030
Figure 3. Glassia Features
Figure 4. Aralast NP Features
Figure 5. Prolastin C Features
Figure 6. Others Features
Figure 7. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Specialty Clinics Case Studies
Figure 11. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Report Years Considered
Figure 12. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Region: 2023 VS 2030
Figure 15. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Players in 2023
Figure 16. Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in 2023
Figure 18. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Country (2019-2030)
Figure 20. United States Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Country (2019-2030)
Figure 24. Germany Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Region (2019-2030)
Figure 32. China Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Country (2019-2030)
Figure 40. Mexico Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Country (2019-2030)
Figure 44. Turkey Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Grifols Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2019-2024)
Figure 47. CSL Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2019-2024)
Figure 48. Baxter Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2019-2024)
Figure 49. Kamada Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2019-2024)
Figure 50. Takeda Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2019-2024)
Figure 51. Abeona Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2019-2024)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
